Παιδιατρική | Τόμος 84 • Tεύχος 1 • Ιανουάριος - Φεβρουάριος - Μάρτιος - Απρίλιος 2021

Page 31

031 23. Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, et al. Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis. JAMA. 2018;319(12):1221-38. 24. Smith A, McNamara PJ, El-Khuffash AF. Non-pharmacological management of a hemodynamically significant patent ductus arteriosus. Semin Fetal Neonatal Med. 2018;23(4):245-9. 25. Clyman RI, Liebowitz M. Treatment and Nontreatment of the Patent Ductus Arteriosus: Identifying Their Roles in Neonatal Morbidity. J Pediatr. 2017;189:13-7. 26. Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe MR, Theyskens C. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007;92(4):F244-7. 27. Bixler GM, Powers GC, Clark RH, Walker MW, Tolia VN. Changes in the Diagnosis and Management of Patent Ductus Arteriosus from 2006 to 2015 in United States Neonatal Intensive Care Units. J Pediatr. 2017;189:105-12. 28. Lokku A, Mirea L, Lee SK, Shah PS, Canadian Neonatal N. Trends and Outcomes of Patent Ductus Arteriosus Treatment in Very Preterm Infants in Canada. Am J Perinatol. 2017;34(5):441-50. 29. Juszczak E, Gupta S. Continued uncertainty regarding treatment of patent ductus arteriosus in premature infants and the role of clinical trials. Semin Fetal Neonatal Med. 2018;23(4):26772.


Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.